Cargando…

Aberrant paracrine signalling for bone remodelling underlies the mutant histone-driven giant cell tumour of bone

Oncohistones represent compelling evidence for a causative role of epigenetic perturbations in cancer. Giant cell tumours of bone (GCTs) are characterised by a mutated histone H3.3 as the sole genetic driver present in bone-forming osteoprogenitor cells but absent from abnormally large bone-resorbin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cottone, Lucia, Ligammari, Lorena, Lee, Hang-Mao, Knowles, Helen J., Henderson, Stephen, Bianco, Sara, Davies, Christopher, Strauss, Sandra, Amary, Fernanda, Leite, Ana Paula, Tirabosco, Roberto, Haendler, Kristian, Schultze, Joachim L., Herrero, Javier, O’Donnell, Paul, Grigoriadis, Agamemnon E., Salomoni, Paolo, Flanagan, Adrienne M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750984/ https://www.ncbi.nlm.nih.gov/pubmed/36138226 http://dx.doi.org/10.1038/s41418-022-01031-x

Ejemplares similares

Multifocal osteoclast-rich tumour in Paget bone disease and conventional giant cell tumour, two genetically distinct entities? Sequencing from a single case
por: Haefliger, Simon, et al.
Publicado: (2023)

Frequent alterations in p16/CDKN2A identified by immunohistochemistry and FISH in chordoma
por: Cottone, Lucia, et al.
Publicado: (2020)

H3F3A (Histone 3.3) G34W Immunohistochemistry: A Reliable Marker Defining Benign and Malignant Giant Cell Tumor of Bone
por: Amary, Fernanda, et al.
Publicado: (2017)

Optimizing CRISPR/Cas9 Editing of Repetitive Single Nucleotide Variants
por: Usher, Inga, et al.
Publicado: (2022)

Synovial chondromatosis and soft tissue chondroma: extra-osseous cartilaginous tumours defined by FN1 gene rearrangement
por: Amary, Fernanda, et al.
Publicado: (2019)

Calvarial Suture-Derived Stem Cells and Their Contribution to Cranial Bone Repair
por: Doro, Daniel H., et al.
Publicado: (2017)

Clinical outcome in patients with peripherally‐sited atypical lipomatous tumours and dedifferentiated liposarcoma
por: Kalimuthu, Sangeetha N, et al.
Publicado: (2015)

DNA methylation‐based profiling of bone and soft tissue tumours: a validation study of the ‘DKFZ Sarcoma Classifier’
por: Lyskjær, Iben, et al.
Publicado: (2021)

Isocitrate dehydrogenase 1 mutations (IDH1) and p16/CDKN2A copy number change in conventional chondrosarcomas
por: Amary, M. Fernanda, et al.
Publicado: (2014)

EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen
por: Scheipl, Susanne, et al.
Publicado: (2016)

Regulation of bone metabolism by megakaryocytes in a paracrine manner
por: Lee, Young-Sun, et al.
Publicado: (2020)

Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast‐rich mimics
por: Presneau, Nadège, et al.
Publicado: (2015)

Drivers underpinning the malignant transformation of giant cell tumour of bone
por: Fittall, Matthew W, et al.
Publicado: (2020)

Small animal models for the study of bone sarcoma pathogenesis:characteristics, therapeutic interests and limitations
por: Jacques, Camille, et al.
Publicado: (2018)

Digital PCR analysis of circulating tumor DNA: a biomarker for chondrosarcoma diagnosis, prognostication, and residual disease detection
por: Gutteridge, Alice, et al.
Publicado: (2017)

Paracrine Effects of Recombinant Human Adiponectin Promote Bone Regeneration
por: Gong, Yanping, et al.
Publicado: (2021)

Sarcoma and the 100,000 Genomes Project: our experience and changes to practice
por: Prendergast, Sophie C, et al.
Publicado: (2020)

Recurrent rearrangements of FOS and FOSB define osteoblastoma
por: Fittall, Matthew W., et al.
Publicado: (2018)

Reconstruction of mandibular defects with autogenous bone and decellularized bovine bone grafts with freeze-dried bone marrow stem cell paracrine factors
por: Kakabadze, Ann, et al.
Publicado: (2017)

Giant Cell Lesions of the Craniofacial Bones
por: Flanagan, Adrienne M., et al.
Publicado: (2014)

Vitamin D and Bone: A Story of Endocrine and Auto/Paracrine Action in Osteoblasts
por: van Driel, Marjolein, et al.
Publicado: (2023)

Chromosomal aberrations and bone marrow toxicity.
por: Heddle, J A, et al.
Publicado: (1981)

Aberrant bone metabolism in critical illness
por: Vanhees, I, et al.
Publicado: (2012)

Paracrine and endocrine actions of bone—the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts
por: Han, Yujiao, et al.
Publicado: (2018)

Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapy
por: Fernanda Amary, M, et al.
Publicado: (2014)

Differential Regulation of Human Bone Marrow Mesenchymal Stromal Cell Chondrogenesis by Hypoxia Inducible Factor‐1α Hydroxylase Inhibitors
por: Taheem, Dheraj K., et al.
Publicado: (2018)

Secretion of MCP-1 and other paracrine factors in a novel tumor-bone coculture model
por: Schiller, Katherine R, et al.
Publicado: (2009)

PTHrP Induces Autocrine/Paracrine Proliferation of Bone Tumor Cells through Inhibition of Apoptosis
por: Mak, Isabella W. Y., et al.
Publicado: (2011)

Paracrine Effect of Mesenchymal Stem Cells Derived from Human Adipose Tissue in Bone Regeneration
por: Linero, Itali, et al.
Publicado: (2014)

Paracrine Mechanisms of Intravenous Bone Marrow-Derived Mononuclear Stem Cells in Chronic Ischemic Stroke
por: Bhasin, Ashu, et al.
Publicado: (2016)

Autocrine and paracrine STIP1 signaling promote osteolytic bone metastasis in renal cell carcinoma
por: Wang, Jiang, et al.
Publicado: (2017)

Altered paracrine signaling from the injured knee joint impairs postnatal long bone growth
por: Roselló-Díez, Alberto, et al.
Publicado: (2017)

The Paracrine Role of Endothelial Cells in Bone Formation via CXCR4/SDF-1 Pathway
por: Tamari, Tal, et al.
Publicado: (2020)

Radiological Features of Giant Cell Tumours of Bone
por: Howard, Emma L, et al.
Publicado: (2020)

Paracrine control of tissue regeneration and cell proliferation by Caspase-3
por: Boland, K, et al.
Publicado: (2013)

Bone Marrow Stem Cell Derived Paracrine Factors for Regenerative Medicine: Current Perspectives and Therapeutic Potential
por: Burdon, Tom J., et al.
Publicado: (2011)

Palmitate Promotes the Paracrine Effects of Macrophages on Vascular Smooth Muscle Cells: The Role of Bone Morphogenetic Proteins
por: Chung, Ji Hyung, et al.
Publicado: (2012)

Bone Marrow Mesenchymal Stromal Cells Stimulate Skeletal Myoblast Proliferation through the Paracrine Release of VEGF
por: Sassoli, Chiara, et al.
Publicado: (2012)

Correction: Paracrine Effect of Mesenchymal Stem Cells Derived from Human Adipose Tissue in Bone Regeneration
Publicado: (2015)

Paracrine Effects of Bone Marrow Mononuclear Cells in Survival and Cytokine Expression after 90% Partial Hepatectomy
por: Kieling, Carlos Oscar, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7aic0p0sen2j4rpju83fnges9o